Differences in pharmacokinetics and ex vivo antioxidant activity following intravenous and oral administrations of emodin to rats.
about
Sensitive and robust UPLC-MS/MS method to determine the gender-dependent pharmacokinetics in rats of emodin and its glucuronideEmodin enhances alveolar epithelial barrier function in rats with experimental acute pancreatitis.Species and gender differences affect the metabolism of emodin via glucuronidationQuantification of conjugated metabolites of drugs in biological matrices after the hydrolysis with β-glucuronidase and sufatase: a review of bio-analytical methods.Pharmacokinetics of anthraquinones in rat plasma after oral administration of a rhubarb extract.Suppression of the pregnane X receptor during endoplasmic reticulum stress is achieved by down-regulating hepatocyte nuclear factor-4α and up-regulating liver-enriched inhibitory protein.Analysis of the pharmacokinetics and metabolism of aloe-emodin following intravenous and oral administrations in rats.Use of liquid chromatography hybrid triple-quadrupole mass spectrometry for the detection of emodin metabolites in rat bile and urine.Development of Certain Protein Kinase Inhibitors with the Components from Traditional Chinese Medicine.Dose-dependent role of novel agents emodin and BTB14431 in colonic cancer treatment in rats.Emodin and Its Role in Chronic Diseases.Emodin: A Review of its Pharmacology, Toxicity and Pharmacokinetics.Yinchenhao Decoction Ameliorates Alpha-Naphthylisothiocyanate Induced Intrahepatic Cholestasis in Rats by Regulating Phase II Metabolic Enzymes and Transporters.Glucuronidation: driving factors and their impact on glucuronide disposition
P2860
Q33567154-C7C5F389-A582-4175-A3F6-D9C6755B873EQ33935583-6C20C3C3-DB64-4000-822A-60AD88832F3CQ33954631-4E09C79E-2FD3-4DD7-B7F9-0B823945AF75Q34708135-9456631A-6F28-4C0B-A10A-02EDF01D1263Q35020126-DFECE9E2-1E0A-4444-BD0E-ADF0B0F25E99Q35214618-66667DBD-475E-4597-98FA-8942AD306FACQ35984667-E5DAAEE2-9D6E-46EA-8892-CCCB45EFD0BFQ36322985-F914343E-862C-4D95-9535-1ED68822127BQ37570454-A18C381B-5902-4248-AADE-51A5687061DFQ38698007-B1301287-408B-4131-AFB0-10F809C0B7EFQ38817374-FEF1BDF2-25B9-45A5-AB2D-6B3B8CA33FD5Q38836434-6E539D05-9B36-43D3-98AE-DCE38F66BAC2Q54987110-1D9075B7-500B-4570-A6A4-E9ED56CC57E5Q56030213-8D831026-DFCC-4636-8232-407F94AB1CAC
P2860
Differences in pharmacokinetics and ex vivo antioxidant activity following intravenous and oral administrations of emodin to rats.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Differences in pharmacokinetic ...... nistrations of emodin to rats.
@en
Differences in pharmacokinetic ...... nistrations of emodin to rats.
@nl
type
label
Differences in pharmacokinetic ...... nistrations of emodin to rats.
@en
Differences in pharmacokinetic ...... nistrations of emodin to rats.
@nl
prefLabel
Differences in pharmacokinetic ...... nistrations of emodin to rats.
@en
Differences in pharmacokinetic ...... nistrations of emodin to rats.
@nl
P2093
P356
P1476
Differences in pharmacokinetic ...... nistrations of emodin to rats.
@en
P2093
Chi-Sheng Shia
Pei-Dawn Lee Chao
Pei-Hsun Huieh
Shang-Yuan Tsai
Yann-Lii Leu
P304
P356
10.1002/JPS.21978
P407
P50
P577
2010-04-01T00:00:00Z